"Medical Research on new therapies for diseases"

During the past decade, Michigan Center of Medical Research conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 3 clinical trials were completed, i.e. on average, 17.6% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 3 clinical trials were completed. i.e. 27.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Michigan Center of Medical Research" #1 sponsor was "Helsinn Healthcare SA" with 2 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Astex Pharmaceuticals, Inc." with 1 trials sponsored and "BeyondSpring Pharmaceuticals Inc." with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Michigan Center of Medical Research" #1 collaborator was "Clinipace Worldwide" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Michigan Center of Medical Research" are "Acute Myeloid Leukemia" (2 trials), "COVID-19" (2 trials), "Myelodysplastic Syndromes" (2 trials), "Non-Small Cell Lung Cancer" (2 trials) and "Advanced Breast Cancer" (1 trials). Many other conditions were trialed in "Michigan Center of Medical Research" in a lesser frequency.

Most popular intervention types in "Michigan Center of Medical Research" are "Drug" (14 trials), "Other" (3 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Azacitidine" (2 trials), "Guselkumab Dose 1" (2 trials), "Guselkumab Dose 2" (2 trials) and "Guselkumab Dose 3" (2 trials). Other intervention names were less common.

The vast majority of trials in "Michigan Center of Medical Research" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Michigan Center of Medical Research". undefined are not yet recruiting, 8 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Michigan Center of Medical Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Michigan Center of Medical Research, 4 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".